Contributors

Headshot
Host

Ted Giovanis

Theodore (Ted) Giovanis, FHFMA, MBA, is President and Founder of the Jayne Koskinas Ted Giovanis Foundation for Health and Policy. He previously led consulting firms focused on health policy, reimbursement, and advocacy for a wide range of healthcare clients. He’s a recognized expert in Medicare and Medicaid policy, regulation, and reimbursement. Notably, he identified and led litigation on the rural floor budget neutrality issue, resulting in a multibillion-dollar hospital settlement. He chaired the Maryland Community Services Reimbursement Rate Commission, appointed by governors from both parties, reflecting his bipartisan credibility. Ted has served as a hospital CFO, controller, and auditor, and helped design Maryland’s GIR and TPR payment systems. He is also a professional sports car driver and team owner of TeamTGM.

https://www.tedgiovanis.com/

Guests

Headshot
Guest

Andrew Ewald

Dr. Andrew Ewald studies how cells build organs and how these processes contribute to cancer metastasis. His lab recently identified a unique class of breast cancer cells that lead invasion into surrounding tissues—a key first step in metastasis. Ongoing research explores whether these cells are viable therapeutic targets. Dr. Ewald earned his undergraduate degree in physics from Haverford College and a Ph.D. in biochemistry and molecular physics from Caltech. He completed postdoctoral work in mammary biology and cancer at UCSF. He joined Johns Hopkins in 2008 and is now director of the Department of Cell Biology, director of the Giovanis Institute for Translational Cell Biology, and holds the Virginia De Acetis Professorship in Basic Cancer Research. He is a member of the American Association for Cancer Research, Society for Developmental Biology, and American Society for Cell Biology. In 2011, he received the Morphological Sciences Award for work in epithelial morphogenesis.

Guest appearance on:

Headshot
Guest

Laura Heiser

Laura Heiser, PhD, Vice Chair of the Department of Biomedical Engineering at Oregon Health and Science University (OHSU) and co-leader of the Quantitative Oncology Program at OHSU Knight Cancer Center. Dr. Heiser's work aims to find smarter therapies for patients with hard-to-treat cancers.